American Journal of Cardiovascular Drugs
Adis, Springer Healthcare
Journal websitePeer review: Peer review
Evaluation status available after sign-in
About the journal
American Journal of Cardiovascular Drugs is a journal published by Adis, Springer Healthcare in Switzerland. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,390 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Adis, Springer Healthcare
- ISSN
- 1175-3277 · 1179-187X
- Country
- Switzerland
- Access
- Not open access / not declared
- Declared publication charge
- 4,390 EUR
- Declared peer-review model
- peer_review
- Official website
- https://link.springer.com/journal/40256
Index listings
- MEDLINE · 2001-01-01
- PUBMED · 2011-06-01
- Indexing
- MEDLINE · PUBMED
- APC
- 4,390 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 138 days received→accepted — computed from PubMed (n=62)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1398
Last recorded publication year
2026
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
72
i10-index
745
From OpenAlex open data (CC0).
Editorial & policy6
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 80%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity4
- Alternate titles
- Drugs, devices, and other interventionsCardiovascular drugs
- Source type
- journal
- NLM unique ID (PubMed)
- 100967755
- Society affiliations
- International Academy of Cardiovascular Sciences
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Lipoproteins and Cardiovascular Health
- Atrial Fibrillation Management and Outcomes
- Atrial Fibrillation Management and Outcomes
- Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health
- Heart Failure Treatment and Management
- Blood Pressure and Hypertension Studies
- Antiplatelet Therapy and Cardiovascular Diseases
Show all subjects (75)
- Antiplatelet Therapy and Cardiovascular Diseases
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Heart Failure Treatment and Management
- Blood Pressure and Hypertension Studies
- Blood Pressure and Hypertension Studies
- Acute Myocardial Infarction Research
- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Acute Myocardial Infarction Research
- Venous Thromboembolism Diagnosis and Management
- Venous Thromboembolism Diagnosis and Management
- Venous Thromboembolism Diagnosis and Management
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Renin-Angiotensin System Studies
- Diabetes Treatment and Management
- Heart rate and cardiovascular health
- Blood Coagulation and Thrombosis Mechanisms
- Cholesterol and Lipid Metabolism
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hormonal Regulation and Hypertension
- Hormonal Regulation and Hypertension
- Coronary Interventions and Diagnostics
- Coronary Interventions and Diagnostics
- Acute Ischemic Stroke Management
- Cardiovascular Function and Risk Factors
- Cardiovascular Function and Risk Factors
- Cardiac electrophysiology and arrhythmias
- Cardiovascular Function and Risk Factors
- Cardiac electrophysiology and arrhythmias
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Lipid metabolism and disorders
- Cardiac Arrhythmias and Treatments
- Cardiac Arrhythmias and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Imaging and Diagnostics
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Imaging and Diagnostics
- Health Systems, Economic Evaluations, Quality of Life
- Pharmacogenetics and Drug Metabolism
- Cardiovascular Health and Disease Prevention
- Medication Adherence and Compliance
- Medication Adherence and Compliance
- Cardiac electrophysiology and arrhythmias
- Pharmacology and Obesity Treatment
- Pharmacology and Obesity Treatment
- Renin-Angiotensin System Studies
- Hormonal Regulation and Hypertension
- Renin-Angiotensin System Studies
- Heart rate and cardiovascular health
- Heart rate and cardiovascular health
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Cancer, Lipids, and Metabolism
- Cardiac pacing and defibrillation studies
- Cardiac pacing and defibrillation studies
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Chronic Kidney Disease and Diabetes
- Cardiac Imaging and Diagnostics
- Pulmonary Hypertension Research and Treatments
- Pulmonary Hypertension Research and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac, Anesthesia and Surgical Outcomes
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ